Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2019 Apr 2:10:484.
doi: 10.3389/fimmu.2019.00484. eCollection 2019.

Editorial: Autoantibodies

Rikard Holmdahl  1 , Falk Nimmerjahn  2 , Ralf J Ludwig  3
Affiliations
Editorial

Editorial: Autoantibodies

Rikard Holmdahl et al. Front Immunol. .
No abstract available

Keywords: arthritis; autoantibody; biomarker; diagnos; pathogenesis; pemphigoid; pemphigus; treatment.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Interaction network of articles within the Research Topic “Autoantibodies”. Keywords of all 88 articles were downloaded from the website of the Research Topic “Autoantibodies” (https://www.frontiersin.org/research-topics/6220/autoantibodies). Cytoscape (https://cytoscape.org/) was used to draw the interaction map. Each line represents an interaction among the keywords, whereas the size of the red circles correlates to the number of times the respective keyword was mentioned. We thank Dr. Yask Guta (University of Lübeck) for generating this figure.
See this image and copyright information in PMC

Comment on

  • Editorial on the Research Topic Autoantibodies

Similar articles

See all similar articles

Cited by

References

    1. Schmidt E, Zillikens D. Pemphigoid diseases. Lancet. (2013) 381:320–32. 10.1016/S0140-6736(12)61140-4 - DOI - PubMed
    1. Hammers CM, Stanley JR. Mechanisms of disease: pemphigus and bullous pemphigoid. Annu Rev Pathol. (2016) 11:175–97. 10.1146/annurev-pathol-012615-044313 - DOI - PMC - PubMed
    1. Witte M, Zillikens D, Schmidt E. Diagnosis of autoimmune blistering diseases. Front. Med. (2018) 5:296. 10.3389/fmed.2018.00296 - DOI - PMC - PubMed
    1. Lamberts A, Yale M, Grando SA, Horváth B, Zillikens D, Jonkman MF. Unmet needs in pemphigoid diseases: an international survey amongst patients, clinicians and researchers. Acta Derm Venereol. (2018) 99:224–5. 10.2340/00015555-3052 - DOI - PubMed
    1. Alexander T, Sarfert R, Klotsche J, Kühl AA, Rubbert-Roth A, Lorenz HM, et al. . The proteasome inhibitior bortezomib depletes plasma cells and ameliorates clinical manifestations of refractory systemic lupus erythematosus. Ann Rheum Dis. (2015) 74:1474–8. 10.1136/annrheumdis-2014-206016 - DOI - PMC - PubMed

Publication types

LinkOut - more resources